emis

Novo Nordisk Inks Insulin Pill Development Pact with Emisphe

Published on Tue, 12/21/2010 - 12:55
By FNN Staff in General Interest, emis, nvo, adr, diabetes, emis, emisphere, inject, insulin, novo nordsik, nvo, oral, patients, pill, shares, tech
adr, diabetes, emis, emisphere, inject, insulin, novo nordsik, nvo, oral, patients, pill, shares, tech

Novo Nordisk (NVO) ADRs are down after the company said it had signed a deal with Emisphere Technologies (EMIS) to use that firm's technology to develop an oral insulin pill, according to a company statement. Currently, there are

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Shares of Exide Technologies Fall to a N...

Exide Technologies (NASDAQ:XIDE) traded at a new 52-week low today of $0.39. So far to ...

MEMC Electronic Materials Looks to Conti...

MEMC Electronic Materials (NYSE:WFR) traded today at a new 52-week high of $7.52. Appr ...

Shares of Wendy's/Arby's Group Rise to a...

Shares of Wendy's/Arby's Group (NASDAQ:WEN) traded at a new 52-week high today of $6.23 ...

Valeant Pharmaceuticals International: T...

Valeant Pharmaceuticals International (NYSE:VRX) traded today at a new 52-week high of ...

Shares of Vanda Pharmaceuticals Rise to ...

Vanda Pharmaceuticals (NASDAQ:VNDA) traded at a new 52-week high today of $8.60. Appro ...

TeleNav: The Losing Streak Continues (TN...

TeleNav (NASDAQ:TNAV) traded at a new 52-week low today of $4.91. So far today approxi ...

Stewart Enterprises Looks to Continue to...

Shares of Stewart Enterprises (NASDAQ:STEI) traded today at $9.83, breaking its 52-week ...

Shares of Semiconductor Manufacturing Ri...

Semiconductor Manufacturing (NYSE:SMI) traded at a new 52-week high today of $4.41. So ...

Most Popular Video News